Factors Affecting Quality of Life at Different Intervals After Treatment of Localized Prostate Cancer: Unique Influence of Treatment Decision Making Satisfaction, Personality and Sexual Functioning

详细信息    查看全文

• 作者：David E. Victorson^a ; ^{d-victorson@northwestern.edu" class="auth_mail" title="E-mail the corresponding author} ; Stephanie Schuette^a ; Benjamin D. Schalet^a ; Shilajit D. Kundu^b ; Brian T. Helfand^c ; Kristian Novakovic^c ; Nathaniel Sufrin^c ; Michael McGuire^c ; Charles Brendler^c
• 关键词：prostatic neoplasms ; quality of life ; decision making ; neuroticism ; surveys and questionnaires
• 刊名：The Journal of Urology
• 出版年：2016
• 出版时间：November 2016
• 年：2016
• 卷：196
• 期：5
• 页码：1422-1428
• 全文大小：292 K

文摘

Using patient reported outcomes measures we identified the most informative set of factors associated with quality of life in a large sample of men treated for localized prostate cancer.

Materials and Methods

We examined relationships with quality of life using FACIT (Functional Assessment of Chronic Illness Therapy). We also hypothesized variables in a sample of men diagnosed with localized prostate cancer who represented different time points since treatment, including less than 12 months in 70, 1 to 3 years in 344, greater than 3 to 5 years in 291 and greater than 5 years in 97. Correlative measures included subscales of MAX-PC (Memorial Anxiety Scale for Prostate Cancer), short forms of PROMIS® and SOMS (Surgical Outcomes Measurement System), TDM-SATS (Treatment Decision-Making Satisfaction Scale) and subscales of the BFI (Big Five Inventory) of personality.

Results

Quality of life was significantly associated with hypothesized variables across different time cohorts. In regression models several factors accounted for most of the variability in quality of life scores depending on time since treatment, including 47%, 22%, 29% and 27% at less than 12 months, 1 to 3 years, greater than 3 to 5 years and greater than 5 years, respectively. Upon examining the unique contribution of these variables, treatment decision making satisfaction was the only variable to have a significant and unique contribution to quality of life across all 4 time cohorts (standardized coefficients 0.33, 0.27, 0.31 and 0.49, respectively, p <0.01). In the cohort with 1 to 3 years since treatment erectile function and neurotic personality style also had unique associations with quality of life (standardized coefficients 0.25 and −0.20, respectively).

Conclusions

When considering the short-term and the longer term quality of life of a man after treatment for localized prostate cancer, our findings highlight the importance of treatment decision making satisfaction, erectile function and personality.